Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518000, China.
Children's Hospital of Philadelphia; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Genes Dev. 2022 Aug 1;36(15-16):871-873. doi: 10.1101/gad.350107.122.
Bmi1 is essential for normal and leukemic hematopoiesis, but its target genes in hematopoietic stem cells (HSCs) are incompletely understood. In this issue of , Burgess et al. (pp. 887-900) demonstrate a novel role of Bmi1 in regulating ribosome biogenesis and protein synthesis. -deficient HSCs exhibited reduced transplantability, with the up-regulation of ARX and genes involved in ribosome biogenesis. However, depletion of or its known targets, , only partially rescues loss-induced hematopoietic defects. They further demonstrate an increased protein synthesis rate and resultant proteostatic stress in HSCs, indicating a novel mechanism by which Bmi1 controls HSC maintenance.
BMI1 对于正常和白血病造血是必不可少的,但它在造血干细胞(HSCs)中的靶基因尚不完全清楚。在本期的《细胞》杂志中,Burgess 等人(第 887-900 页)展示了 BMI1 在调节核糖体生物发生和蛋白质合成中的新作用。BMI1 缺陷的 HSCs 的移植能力降低,ARX 及其参与核糖体生物发生的基因上调。然而,耗尽 或其已知的靶点, ,仅部分挽救了 缺失诱导的造血缺陷。他们进一步证明了 缺失的 HSCs 中蛋白质合成率增加和由此产生的蛋白质稳态应激,表明了 BMI1 控制 HSC 维持的新机制。